|
NL154600B
(nl)
|
1971-02-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
|
|
US3949064A
(en)
|
1973-10-26 |
1976-04-06 |
Baxter Laboratories, Inc. |
Method of detecting antigens or antibodies
|
|
US4174384A
(en)
|
1975-06-30 |
1979-11-13 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5981724A
(en)
|
1991-10-25 |
1999-11-09 |
Immunex Corporation |
DNA encoding CD40 ligand, a cytokine that binds CD40
|
|
PT1024191E
(pt)
|
1991-12-02 |
2008-12-22 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
|
US6998116B1
(en)
*
|
1996-01-09 |
2006-02-14 |
Genentech, Inc. |
Apo-2 ligand
|
|
US6030945A
(en)
*
|
1996-01-09 |
2000-02-29 |
Genentech, Inc. |
Apo-2 ligand
|
|
JP2002533118A
(ja)
*
|
1998-12-29 |
2002-10-08 |
ユニバーシティ オブ バーモント アンド ステイト アグリカルチャー カレッジ |
Ｔ細胞レセプター使用を改変するためのｃｄ４０係合の使用
|
|
US6946129B1
(en)
*
|
1999-06-08 |
2005-09-20 |
Seattle Genetics, Inc. |
Recombinant anti-CD40 antibody and uses thereof
|
|
AU6934600A
(en)
*
|
1999-08-27 |
2001-03-26 |
Board Of Regents, The University Of Texas System |
Cd40 ligand and cd40 agonist compositions and methods of use
|
|
WO2001026608A2
(en)
*
|
1999-10-14 |
2001-04-19 |
Ledbetter Jeffrey A |
Dna vaccines encoding antigen linked to a domain that binds cd40
|
|
CA2399790C
(en)
*
|
2000-02-02 |
2012-10-30 |
Ralph A. Tripp |
Cd40 ligand adjuvant for respiratory syncytial virus
|
|
CA2430013C
(en)
|
2000-11-30 |
2011-11-22 |
Medarex, Inc. |
Transgenic transchromosomal rodents for making human antibodies
|
|
US7829084B2
(en)
*
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
AR039067A1
(es)
|
2001-11-09 |
2005-02-09 |
Pfizer Prod Inc |
Anticuerpos para cd40
|
|
ES2400660T3
(es)
*
|
2005-11-01 |
2013-04-11 |
Novartis Ag |
Usos de anticuerpos anti-CD40
|
|
EP1951862B1
(en)
*
|
2005-11-07 |
2013-07-24 |
MicroVAX, LLC |
Cd40 ligand fusion protein vaccine
|
|
AR060487A1
(es)
*
|
2006-04-21 |
2008-06-18 |
Xoma Technology Ltd |
Composiciones farmaceuticas de antagonistas del anticuerpo anti- cd40
|
|
CN101657464A
(zh)
|
2007-02-02 |
2010-02-24 |
贝勒研究院 |
与靶向人源化单克隆抗体复合的多变量抗原
|
|
ES2685823T3
(es)
*
|
2008-07-16 |
2018-10-11 |
Baylor Research Institute |
Anticuerpos antagonistas anti-CD40
|
|
AU2010222942B2
(en)
*
|
2009-03-10 |
2013-01-10 |
Baylor Research Institute |
Anti-CD40 antibodies and uses thereof
|
|
CN102770457A
(zh)
|
2009-03-10 |
2012-11-07 |
贝勒研究院 |
靶向抗原呈递细胞的疫苗
|
|
DK2406289T3
(en)
|
2009-03-10 |
2017-05-01 |
Baylor Res Inst |
ANTIGEN PRESENTING CELL TARGETED ANTIVIRUS VACCINES
|
|
KR20130108295A
(ko)
|
2010-08-13 |
2013-10-02 |
베일러 리서치 인스티튜트 |
항원-제시 세포에 항체에 대한 보조제를 직접 표적화함을 기초로 하는 신규 백신 보조제
|
|
ES2709654T3
(es)
|
2011-04-29 |
2019-04-17 |
Apexigen Inc |
Anticuerpos anti-CD40 y métodos de uso
|
|
WO2014121099A1
(en)
*
|
2013-01-31 |
2014-08-07 |
Thomas Jefferson University |
Agonist fusion protein for cd40 ox40 and uses thereof
|
|
AU2014233114B2
(en)
*
|
2013-03-15 |
2018-03-08 |
Richard S. Kornbluth |
Composition comprised of antigen linked to a TNF SuperFamily ligand
|
|
CN120939216A
(zh)
|
2014-01-13 |
2025-11-14 |
贝勒研究院 |
抗hpv和hpv相关的疾病的新疫苗
|
|
MA41460A
(fr)
*
|
2015-02-03 |
2017-12-12 |
Oncomed Pharm Inc |
Agents de liaison à la tnfrsf et leurs utilisations
|
|
ES2754432T3
(es)
*
|
2015-05-04 |
2020-04-17 |
Apogenix Ag |
Proteínas agonistas de receptor CD40 de cadena sencilla
|
|
DE112016006501T5
(de)
|
2016-02-26 |
2018-11-29 |
Mitsubishi Electric Corp. |
Zündspulenvorrichtung für Verbrennungsmotor
|
|
WO2017165464A1
(en)
|
2016-03-21 |
2017-09-28 |
Elstar Therapeutics, Inc. |
Multispecific and multifunctional molecules and uses thereof
|
|
US12297266B2
(en)
*
|
2016-04-18 |
2025-05-13 |
Celldex Therapeutics, Inc. |
Agonistic antibodies that bind human CD40 and uses thereof
|
|
TWI761348B
(zh)
|
2016-05-27 |
2022-04-21 |
美商艾伯維生物醫療股份有限公司 |
抗cd40抗體及其用途
|
|
US10610585B2
(en)
*
|
2017-09-26 |
2020-04-07 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods and compositions for treating and preventing HIV
|
|
JP7676150B2
(ja)
*
|
2018-06-01 |
2025-05-14 |
サノフイ |
Ｂ型肝炎ウイルス感染を治療するための併用療法
|